T0	Participants 548 665	Two hundred and twenty-nine adult patients with differentiated thyroid cancer requiring radioiodine WBS were studied.
T1	Participants 1371 1429	patients with disease or tissue limited to the thyroid bed
T2	Participants 1452 1508	100% of patients, respectively, with metastatic disease.
T3	Participants 1639 1697	patients with disease or tissue limited to the thyroid bed
T4	Participants 1710 1743	patients with metastatic disease.
T5	Participants 1883 1960	patients undergoing evaluation for thyroid cancer persistence and recurrence.